FDA 483 - Intersect ENT, Inc. - March 06, 2019

Intersect ENT, Inc. in Menlo Park, CA, was cited with four observations during an FDA inspection for deficiencies in quality control, labeling operations, complaint handling, and employee training. The findings indicate a failure to adhere to established standard operating procedures and current good manufacturing practices, potentially impacting product quality and safety.